发明名称 |
Use of Bacterial Beta-Lactamase for In Vitro Diagnostics and In Vivo Imaging, Diagnostics and Therapeutics |
摘要 |
Provided herein provided is an assay system for monitoring drug susceptibility of a pathogenic bacteria comprising color-producing substrates for a beta-lactamase of the pathogenic bacteria, an assay device for visibly detecting a product of the beta-lactamase on the substrate thereof and a reader configured to quantify the visibly detected product. Also provided is an in vitro method to determine susceptibility to a drug effective against a pathogenic bacteria, for example, a pathogenic Mycobacteria, that has a beta-lactamase activity. An excitation wavelength is delivered to a biological sample obtained from a subject having an infection from the pathogenic bacteria in the presence of a beta-lactamase substrate. The intensity of a signal, such as a fluorescent, luminescent or colorimetric signal, at an emission wavelength of a product of the beta-lactamase on the subject is correlated to drug susceptibility. |
申请公布号 |
US2016376629(A1) |
申请公布日期 |
2016.12.29 |
申请号 |
US201615262374 |
申请日期 |
2016.09.12 |
申请人 |
Cirillo Jeffrey D.;Rao Jianghong |
发明人 |
Cirillo Jeffrey D.;Rao Jianghong |
分类号 |
C12Q1/18;G01N21/64;G01N21/78 |
主分类号 |
C12Q1/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. An assay system for monitoring drug susceptibility of pathogenic bacteria, comprising:
one or more color-producing substrates for a beta-lactamase of the pathogenic bacteria; an assay device for visibly detecting a product of beta-lactamase activity on the substrate; and a reader configured to quantify visible signals emitted by the detected product. |
地址 |
College Station TX US |